Press Releases


Jul 18, 2018
Cytox White Paper now available on Assessing Alzheimer’s disease risk using polygenic risk scoring biomarkers
Jul 12, 2018
New opportunities for Alzheimer's disease clinical trial design
May 22, 2018
Cytox launches collaboration agreement with Mayo Clinic to evaluate novel genetic based approaches for assessing Alzheimer’s risk
May 8, 2018
Cytox in collaboration with AKESOgen extends genetic test for assessing Alzheimer's disease risk to include saliva samples
Apr 9, 2018
Cytox CEO to present at the Oxford Investment Biotech Investment Showcase
Mar 8, 2018
Cytox awarded new Innovate UK funding for Alzheimer’s disease testing
Mar 7, 2018
Cytox congratulates Professor John Hardy and his fellow winners of this year’s €1m Brain Prize
Nov 2, 2017
New precision medicine approach for assessing Alzheimer’s disease risk presented at CTAD conference in Boston
Jun 15, 2017
Cytox raises £2.6m led by Catapult Ventures to launch predictive testing service for Alzheimer’s disease
Mar 20, 2017
Breakthrough studies describing new precision medicine approach for assessing Alzheimer’s disease risk to be presented at AD/PD conference in Vienna
Dec 1, 2016
Cytox presentations on studies with breakthrough genetic biomarker research assay for Alzheimer’s disease risk assessment at CTAD 2016
Jul 24, 2016
Cytox launches interpretive software for breakthrough genetic biomarker research assay for Alzheimer’s risk assessment at AAIC
Jul 22, 2016
Cytox launches breakthrough genetic biomarker research assay for Alzheimer’s disease risk assessment
Nov 10, 2015
Cytox congratulates Professor John Hardy, first UK winner of $3m Breakthrough Prize in Life Sciences
Nov 2, 2015
CTAD 2015 presentation on the application of SNP profiling to risk stratification in Alzheimer’s disease
Oct 12, 2015
Cytox announces participation in INSIGHT Alzheimer’s study
Sep 15, 2015
Cytox CEO keynote speaker at UKTI thought leadership conference on dementia
Jul 20, 2015
Cytox and Affymetrix form strategic partnership to develop and commercialize blood-based genetic assay for Alzheimer’s disease risk assessment
Jul 14, 2015
Cytox – The application of SNP profiling to risk stratification in Alzheimer’s disease to be presented at AAIC 2015
Jun 1, 2015
Cytox signs research agreement with AIBL and partner organisations
May 12, 2015
CEO to present in Company Showcase
Apr 20, 2015
Cytox awarded Innovate UK funding for stratification of neurodegenerative diseases
Apr 3, 2014
Cytox Closes £1.5M Second Round of Funding for Alzheimer’s biomarker